- Livongo has been awarded a contract to provide the Livongo for Diabetes solution to eligible members covered by the Federal Employees Health Benefits Program (FEHBP ) under one health plan.- The contract is Livongo’s biggest contract in company history and will account for $20-25M in revenue in 2020 and $30-35M in revenue for 2021, representing a total of $50-60M including both years.- The announcement reflects Livongo’s overall market traction and how they are expanding from working primarily
Read More
Q3 2019 Digital Health Funding Levels Off At $1.3B, Rock Health Reports
- New Rock Health report finds digital health funding reaches $1.3B in Q3 2019 for a total of $5.5B year to date. - Large digital health funding round are driving the overall funding trend in digital health with the average deal size at $20.9M, in line with 2018’s $21.7M average deal size. - Rock Health projects the number of digital health deals in 2019 will be 5-10% lower than in 2018.Digital health funding reached a total of $1.3B in Q3 2019 for a total of $5.5B year to date, leveling off
Read More
Livongo, Pager, Wildflower Health, Others Name BCBS Data Innovation Challenge Finalists
The Blue Cross Blue Shield Association (BCBSA) and Blue Health Intelligence® (BHI) has announced the finalists of the BlueCross BlueShield Data Innovation Challenge developing solutions that increase access to care, enhance patient engagement, and improve care delivery and outcomes. The selected finalists will receive access to a limited HIPAA-compliant Blue Health Intelligence (BHI) dataset so they can test their hypotheses.5 BCBS Data Innovation Challenge FinalistsThe five finalists were
Read More
Livongo’s Q2’19 Revenue Reaches $41M, Up 156% Y-o-Y
- Livongo reports Q2 19 total revenue of $40.9 million, up 156% year-over-year- 192,934 enrolled Livongo for Diabetes Members, up 140% year-over-year with 38,170 new Livongo for Diabetes Members in Q2- Total Contract Value of $74.2 million, up from $24.8 million in the second quarter of 2018. Livongo Health, Inc. (NASDAQ: LVGO), an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter
Read More
The Drought is Over: It’s Raining Health IT IPOs
Three venture-backed health IT companies completed IPOs in July, ending an almost three-year drought of health IT IPOs. Share prices soared following each IPO, indicative of the enthusiastic response and a desire to see more health IT companies make their way toward public debuts. Composition of revenue, gross margin, and growth are key differentiators between these and all companies and key drivers of valuation. Given the enthusiastic shareholder response to these listings, we
Read More
Livongo Founder Glen Tullman to Receive “Ripple of Hope” Award
Glen Tullman, Livongo Founder and Executive Chairman
Livongo Founder and Executive Chairman Glen Tullman will be honored with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system.
The Ripple of Hope Award Background
The Ripple of Hope Award celebrates leaders of the international business, entertainment, and activist communities who have demonstrated a commitment to social change. Past
Read More
Research: July Digital Health IPOs, M&A Activity, Public Company Performance Summary
Summary of Health IT/digital IPOs, merger & acquisition (M&A) activity, and public company performance during the month of July.
Digital Health IPOs in July
Source: Healthcare Growth Partners (HGP)
Breaking the digital health IPO drought, there were four initial public offerings (IPOs) during a five-week period from late June to late July, including Livongo, Health Catalyst, Phreesia, and Change Healthcare. The last health IT companies to reach IPO were iRhythym Technologies and
Read More
Livongo to Offer 10.7 Million Shares in IPO, Priced Between $20 & $23 Per Share
Livongo Health, Inc., today announced it plans to offer 10,700,000 shares of its common stock to the public with the price expected to be between $20.00 and $23.00 per share. Livongo has applied to list its common stock on the Nasdaq Global Select Market under the symbol “LVGO.” Livongo also intends to grant the underwriters a 30-day option to purchase up to an additional 1,605,000 shares of common stock from Livongo.Livongo offers an integrated suite of solutions to promote sustainable health
Read More
Rock Health Report: Is 2019 The Year of the Digital Health IPO?
Digital health funding reached a new record of $4.2 billion across 180 deals in the first half of 2019, according to Rock Health, a full-service venture fund dedicated to digital health. The digital health sector is on track for an $8.4B year in 2019—and may even break 2018’s annual funding total. The report also validates the continued trend of the large $100M+ mega deals, attributing to 30% of venture funding in H1 2019. The 2019 Midyear Digital Health Market Update reflects a maturing digital
Read More
Digital Health Company Livongo Files for $100M IPO
Livongo Health, Inc., today announced that it has publicly filed a registration statement for a proposed initial public offering (IPO) of its common stock, according to the U.S. Securities and Exchange Commission (SEC) filing. Livongo has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol "LVGO."Livongo Growth MetricsFounded in 2014, Livongo offers an integrated suite of solutions to promote sustainable health behavior change based on easy, real-time data
Read More